Michael Tassavor, MD
MOHS-Micrographic Surgery · New York, NYNPI 1043707003
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. LEO Pharma Inc. accounts for 81.8% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $47,520, more than ten times the $421 reported in 2021. Among mohs-micrographic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 451 payments — averaging $122.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$45K
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$1K
- Incyte Corporation$742
- Johnson & Johnson$737
- Novartis$666
- plus $5K from 27 others
What the payments were for
- Consulting fees$7,30213%
- Speaking & faculty fees$29,50054%
- Travel & lodging$5,33210%
- Food & beverage$12,90623%
- Education$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 71 | $45,086 |
| AbbVie | 61 | $1,611 |
| E.r. Squibb & Sons, L.L.C. | 76 | $1,454 |
| Incyte Corporation | 28 | $742 |
| Johnson & Johnson | 26 | $737 |
| Novartis | 20 | $666 |
| Arcutis Biotherapeutics, Inc. | 15 | $628 |
| Pfizer | 16 | $594 |
| Lilly USA, LLC | 12 | $485 |
| Regeneron Healthcare Solutions, Inc. | 23 | $478 |
| Dermavant Sciences, Inc. | 7 | $412 |
| UCB, Inc. | 16 | $383 |
| Sun Pharmaceutical Industries Inc. | 13 | $309 |
| Galderma Laboratories, L.p. | 23 | $285 |
| Mayne Pharma Commercial LLC | 10 | $225 |
| Genentech USA, Inc. | 1 | $140 |
| Regeneron | 2 | $131 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $125 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $108 |
| Convatec Inc. | 3 | $68 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $66 |
| Amgen | 4 | $66 |
| Botanix SB Inc | 3 | $52 |
| Organogenesis Inc. | 3 | $48 |
| Organon | 3 | $37 |
| Sanofi | 2 | $36 |
| Boehringer Ingelheim | 1 | $19 |
| Almirall LLC | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Sandoz | 1 | $16 |
| Krystal Biotech Inc | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Biofrontera Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$55,084 in reported general payments places this provider in the 90th percentile of 75 mohs-micrographic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $120,327 |
| Tacrolimus | 27 | $3,659 |
| Clobetasol Propionate | 80 | $3,078 |
| Acitretin | 16 | $2,476 |
| Fluorouracil | 12 | $1,118 |
| Ketoconazole | 42 | $997 |
| Doxycycline Hyclate | 54 | $931 |
| Clindamycin Phosphate | 15 | $658 |
| Triamcinolone Acetonide | 43 | $552 |
| Cefadroxil | 83 | $488 |
| ValacyclovirValacyclovir Hcl | 13 | $260 |
| Mupirocin | 32 | $225 |
| Methylprednisolone | 11 | $147 |
| MethotrexateMethotrexate Sodium | 12 | $125 |
| Hydrocortisone | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in New York
- Ellen MarmurNew York$186K
- Jane YooNew York$42K
- Hamza BhattiNew York$40K
- Desiree RatnerNew York$32K
- Omar Torres LozadaNew York$13K
- Ronald SheltonNew York$10K
- Sarah YagermanNew York$8K
- John CarucciNew York$6K
- Faramarz SamieNew York$5K
- Hooman KhorasaniNew York$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.